Generated: May 29, 2017
|Title:||Method of administering narcotic antagonists and analgesics and novel dosage forms containing same|
|Abstract:||The invention provides a novel method of administering narcotic antagonists, narcotic analgesics and related compounds, and novel dosage forms containing those compounds which are adapted for nasal administration. The nasal dosage forms disclosed include solutions, suspensions, gels and ointments. Especially preferred compounds which can be advantageously administered in accordance with the invention include naloxone, naltrexone, nalbuphine, levorphanol, buprenorphine, butorphanol, .DELTA..sup.9 -tetrahydrocannabinol (THC), cannabidiol (CBD) and levonantradol.|
|Inventor(s):||Hussain; Anwar A. (Lexington, KY)|
|Assignee:||University of Kentucky Research Foundation (Lexington, KY)|
Patent Claim Types:|
see list of patent claims
|Use; Composition; Dosage form; Compound; Delivery; Formulation;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|European Patent Office||0077393||► Subscribe|
|World Intellectual Property Organization (WIPO)||8203768||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.